Clinical Trial Update: Long-term Safety Follow-up Study in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) [Phase 3]

View source ↗

Summary

A Phase 3 long-term safety follow-up trial investigating a preventive approach for bronchiolitis obliterans syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans

Snippet

Sponsor: Pari Pharma GmbH | Conditions: Bronchiolitis Obliterans | Phase 3 | Status: TERMINATED